Looking for Investment, Acquisition, Partnerships or Collaborations?
The Autoimmunity Pharma & Biotech Partnering Summit is the only industry event that creates a hyper-relevant scientific partnering opportunity, to drive external collaboration across disruptive therapies in early innovation, and bring immune reset and reconstitution assets into internal pharma pipelines for expedited development.
EVENT IN NUMBERS
attending companies across modalities so pharma can decide which horse to back in this quickly evolving space
meetings bookable via the partnering portal for efficient and high yielding conversations between decision makers
big pharma leads across business development, search and evaluation, immunology research and venture giving the best, most comprehensive opportunity to meet the full teams assessing due diligence and asset synergy
alignment on interests and intentions, increasing the surface area for synergy in research and collaboration goals
Event Attendees
For biotech business development and corporate strategy
to collaborate together across modalities with potential for combinations, or co-develop with pharma to combine resources and confidently progress past proof-of-concept.
For pharma search and evaluation, business development, and corporate venture
to compare competing and complementary science across modalities in the context of scientific discussion, direct ongoing early development of high potential assets, and grow activity or pipelines in the hotly anticipated immune reset and reconstitution field.